Related Experiment Video
Updated: Jul 20, 2026
06:06
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
Price and purity analysis for illicit drug: data and conceptual issues
1Carnegie Mellon University, Qatar Campus and Heinz School of Public Policy, Doha, Qatar. caulkins@cmu.edu
Drug and Alcohol Dependence
|September 15, 2006
Summary
Understanding illicit drug prices and purity is crucial for policy and research. This paper reviews data challenges and conceptual issues to improve interpretation and guide future research on drug markets.
Area of Science:
- Economics
- Public Health
- Criminology
Background:
- Data on illicit drug purity and prices are valuable but present significant challenges for accurate analysis.
- Despite academic skepticism regarding their suitability for economic analysis, these data are frequently utilized in practice.
Purpose of the Study:
- To review data and conceptual issues surrounding illicit drug price and purity series.
- To provide guidance for producers, analysts, and consumers of these data to minimize misinterpretation.
- To identify poorly understood aspects of drug markets relevant to data interpretation.
Main Methods:
- Literature review of existing data and conceptual frameworks related to drug pricing and purity.
- Analysis of common challenges and potential misinterpretations in drug market data.
- Identification of research gaps and areas for future investigation.
Main Results:
- Illicit drug price and purity data, while challenging, are essential for understanding drug markets.
- Misinterpretation of these data can be reduced by understanding underlying data and conceptual issues.
- Key aspects of drug markets remain poorly understood, highlighting the need for further research.
Conclusions:
- Addressing data and conceptual challenges is vital for the accurate use of illicit drug price and purity information.
- Improved data on drug supply, availability, and use would benefit public health and law enforcement.
- A focused research agenda is proposed to enhance understanding of illicit drug markets.
Related Concept Videos
01:23Drug Concentrations: Measurements
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Plasma —...
01:25Drug Classes and Categories
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...